Edgewise Therapeutics Inc (EWTX) — Financial Flexibility Index
Edgewise Therapeutics Inc (EWTX) has a Financial Flexibility Index of -1.67x as of March 2026. Free cash flow of $-42.28 Million (operating CF $-42.54 Million minus capex $260.00K) represents -2% of total liabilities ($25.32 Million). Check Edgewise Therapeutics Inc (EWTX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Edgewise Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Edgewise Therapeutics Inc across 7 annual periods. See Edgewise Therapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Edgewise Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Edgewise Therapeutics Inc. For the full company profile including market capitalisation, see Edgewise Therapeutics Inc (EWTX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.73x | $-143.56 Million | $-143.82 Million | $30.35 Million | ▼ -21.2% |
| 2024 | -3.90x | $-107.72 Million | $-109.03 Million | $27.60 Million | ▲ +4.0% |
| 2023 | -4.07x | $-86.20 Million | $-91.95 Million | $21.20 Million | ▼ -76.0% |
| 2022 | -2.31x | $-47.09 Million | $-52.63 Million | $20.39 Million | ▲ +23.7% |
| 2021 | -3.03x | $-32.84 Million | $-33.51 Million | $10.85 Million | ▼ -3351.3% |
| 2020 | -0.09x | $-14.43 Million | $-14.63 Million | $164.56 Million | ▲ +59.6% |
| 2019 | -0.22x | $-8.99 Million | $-9.17 Million | $41.39 Million | — |